Strategies and challenges for the next generation of antibody–drug conjugates
2017 · Nature Reviews Drug Discovery · 2,058 citations
https://doi.org/10.1038/nrd.2016.268
C
Charles Dumontet
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
708
Papers
30.2K
Citations
80
h-index
316
i10-index
Charles Dumontet is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Chronic Lymphocytic Leukemia Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 80, co-authored 602 publications.
ORCID: 0000-0003-1875-134XPapers by this author
worksPayload diversification: a key step in the development of antibody–drug conjugates
2023 · Journal of Hematology & Oncology · 210 citations
https://doi.org/10.1186/s13045-022-01397-y
Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP)
2019 · Breast Cancer Research · 131 citations
https://doi.org/10.1186/s13058-018-1088-6
A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial
2018 · Leukemia · 71 citations
https://doi.org/10.1038/s41375-018-0133-x
Differentiation of human colon cancer cells changes the expression of β-tubulin isotypes and MAPs
1999 · British Journal of Cancer · 57 citations
https://doi.org/10.1038/sj.bjc.6690481
Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla
2008 · Fitoterapia · 39 citations
https://doi.org/10.1016/j.fitote.2008.09.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat